BOSTON & GENEVA--(EON: Enhanced Online News)--For the second year PHT Corporation President and CEO Philip Lee is shortlisted for Executive of the Year in the 9th Annual SCRIP Awards competition. PHT is the leading provider of technologies used to collect Patient-Driven eData for clinical research.
“I am honored to be among this group of industry visionaries. I consider it a great privilege to have the opportunity to help pharmaceutical companies leverage new technologies to speed the development of drugs and therapies that improve the health and quality of life of people around the globe.”
The SCRIP awards are unique in recognizing innovation and excellence across the international biopharmaceutical industry. Winners chosen by a panel of luminaries from across the sector will be announced at a black tie gala in London in November.
Phil has been a software industry executive for 20+ years. For the past 11 years Phil has led the way for the global adoption of eClinical technologies to speed new drugs and treatments to patients.
The pharmaceutical and general business communities continue to honor Phil for his vision and achievements: For the second consecutive year he was a finalist for the Ernst & Young New England Region Entrepreneur of the Year award and a finalist for the Massachusetts Technology Leadership Council CEO of the Year. Last year he was named an Innovation All Star by the Boston Business Journal (BBJ) and Mass High Tech. This year Phil led PHT to a spot on the BBJ list of the 100 largest private companies in the New England area. Phil’s recent honors also include being one of the PharmaVOICE 100 most inspiring people in the life sciences industries. Phil is a mentor in the Conexión Leadership and Mentorship Program which pairs successful executives with up-and-coming Latino professionals. He also is a charter member of Boston’s chapter of the Vistage Chief Executives Group.
Phil Lee said, “I am honored to be among this group of industry visionaries. I consider it a great privilege to have the opportunity to help pharmaceutical companies leverage new technologies to speed the development of drugs and therapies that improve the health and quality of life of people around the globe.”
About PHT Corporation
PHT Corporation helps pharmaceutical companies and CROs conduct clinical trial programs with greater confidence, ease and accuracy. Proven PHT electronic clinical outcome assessment (eCOA) Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via StudyWorks™ online reporting portal, provides sponsors and clinicians with a real time window into how patients feel and function. PHT has helped trial sponsors collect patient-driven eData in 650+ global trials resulting in 16+ regulatory approvals. PHT offers the regulatory, technological, and scientific expertise today’s market demands and patients deserve. Visit www.phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Twitter, Google+ and YouTube.